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Accepted 13 May 2014; Published online 4 August 2014AbstractObjectives: To modify and validate in primary health care the Identification of Seniors At Risk (ISAR) screening questionnaire to iden-
tify older persons at increased risk of functional decline and to compare this strategy with risk stratification by age alone.
Study Design and Setting: Prospective development (n 5 790) and validation cohorts (n 5 2,573) of community-dwelling persons
aged 70 years. Functional decline at 12 months was defined as an increase of at least one point on the modified Katzeactivities of daily
living index score compared with baseline or death.
Results: Three items were independently associated with functional decline: age (odds ratio [OR]: 1.06 per year; 95% confidence in-
terval [CI]: 1.02, 1.10), dependence in instrumental activities of daily living (OR: 2.17; 95% CI: 1.46, 3.22), and impaired memory (OR:
2.22; 95% CI: 1.41, 3.51). The area under the receiver operating characteristics curve (AUC) range of the ISAR-primary care model was
0.67e0.70, and 40.6% was identified at increased risk. Validation yielded an AUC range of 0.63e0.64. Age 75 years alone yielded an
AUC range of 0.56e0.57 and identified 55.4% at increased risk in the development cohort.
Conclusion: Although the ISARePrimary Care (ISAR-PC) has moderate predictive value, application of the ISAR-PC is more efficient
than selection based on age alone in identifying persons at increased risk of functional decline.  2014 Elsevier Inc. All rights reserved.
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The occurrence of new disabilities is often called func-
tional decline [1]. This comprises a decline in activities of
daily living (ADL) or instrumental activities of daily living
(IADL).Disabilities are associatedwith loss of independence
[2], need for hospital and nursing home care [3], and mortal-
ity [4]. The annual incidence of (I)ADL disabilities ranged
from 13% to 24% depending, among other things, on the
applied definition [5,6]. Functional decline places a high
burden on social and economic resources in aging societies.
Meta-analyses of preventive interventions, such as
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http://dx.doi.org/10.1016/j.jclinepi.2014.05.014assessment, and multicomponent exercise programs in
community-dwelling older persons demonstrate that func-
tional decline can be postponed [7e10]. Identifying older per-
sons, who may benefit from a preventive intervention, at
increased risk is therefore an important first step [11]. Over
the last decades, considerable effort has been put into the iden-
tification of frail older persons in primary care [12,13].
Different strategies exist for the identification of frail older
persons. It can be based on self-assessment instruments for
older persons [14,15], on the clinical judgment by the general
practitioner (GP) [16] or on the routine health care data from
the GPs’ electronic medical record (EMR) [17].
From the literature, it appears that exclusively focusing
on complex care for frail elderly may not be efficient,
because older persons with no or only mild disabilities
who are at increased risk of functional deterioration are
the most likely to benefit from preventive interventions
[11,18]. Extending preventive efforts toward somewhat
younger people (70e75 years.) and a less frail (‘‘prefrail’’)
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Key findings
 Identification of Seniors At Risk-Primary Care
(ISAR-PC) is a validated, generic, and easy-to-
apply screening instrument to identify persons at
increased risk of functional decline in the open
population. It comprises three items (age, depen-
dence in instrumental activities of daily living,
and impaired memory).
What this adds to what was known?
 Over the last decades, considerable effort has been
paid into the identification of older persons at risk
of functional decline by self-reporting question-
naires in primary care. The ISAR-PC is easily appli-
cable and thoroughly validated in general practice.
What is the implication and what should change
now?
 In general practice, in a population !85 years of
age, the ISAR-PC can be used as an efficient and
validated method to identify persons at increased
risk of functional decline and is more efficient than
selection based on age alone.
population is therefore believed to increase the yield of
comprehensive geriatric assessments and tailored interven-
tions [7,10,11,19].
To identify older persons at increased risk of functional
decline a self-reporting, generic, easy-to-apply, and vali-
dated instrument is needed. Several other well-known
instruments have the ability to predict functional decline
over time, such as the Sherbrooke Postal Questionnaire
[20], Vulnerable Elders Survey [21], the Groningen Frailty
Index [6], Tilburg Frailty Indicator [14], and the Survey of
Health, Ageing and Retirement in Europeeoperationalized
frailty phenotype [22]. However, some screening tools
require external validation in a larger population [6,20] or
in a primary care setting [6,20,21].
The Identification of Seniors At Risk (ISAR) question-
naire is a self-report screening instrument that was vali-
dated to identify older persons at increased risk of
functional decline who visit the emergency department
(ED) [23]. The ISAR is short and easy to administer and
can be completed by patients or informal caregivers.
Because the original ISAR contains risk factors that are
associated with functional decline in community-dwelling
older persons [3,24], we hypothesized that the ISAR could
also be usable in a primary health care setting.
In some European countries, it is policy in primary
health care to conduct annual multidimensional assess-
ments to all persons aged 75 years [25]. Selection byage is frequently used as a starting point for preventive in-
terventions [10]. We hypothesized that the identification of
older persons at increased risk of functional decline by a
simple discriminative screening instrument is more efficient
than based on age alone.
The aims of this study were therefore to (1) assess the
predictive performance of the original ISAR questionnaire
to detect older persons at increased risk of functional
decline and further improve or modify the instrument
where possible, (2) test a modified ISAR questionnaire in
a validation cohort, and (3) compare the performance of
the modified ISAR with risk stratification by age alone.2. Methods
2.1. Design and setting of development and external
validation cohorts
A prospective cohort study was conducted in seven gen-
eral practices in the Netherlands. These practices had a
mixed population in terms of sex, age, and socioeconomic
status (SES) (Appendix A at www.jclinepi.com). Measure-
ments of the development cohort began in October 2008,
and the cohort was monitored for 12 months.
The modified ISAR was externally validated in another
prospective cohort in 10 general practices in a northwestern
region of the Netherlands. Measurements of the external
validation cohort began in December 2010, and the cohort
was monitored for 12 months.
2.2. Participants in development and external validation
cohorts
All community-dwelling persons aged 70 years, regis-
tered in one of the participating general practices, were
retrieved from the EMRs by their GP. Persons were
excluded if they were terminally ill, were demented, did
not understand Dutch, and planned to move or spend a long
time abroad. Eligible persons received a letter from their
GP with information about the study, along with a written
informed consent form, a self-report questionnaire, and a
prepaid envelope. They were invited to fill out the question-
naire themselves, and if they needed help, an informal care-
giver was allowed to assist (this assistance was noted on the
questionnaire). All participants were asked to provide writ-
ten informed consent for data collection and participation
in the study after receipt of the study information. Those
persons unwilling to participate were asked to select one
of three prestructured reasons on a reply card: too ill, not
interested, or lack of time. They could also add their own
comment. A postal reminder was sent after 3 weeks if no
response was received. After 6 weeks, two attempts by
phone were made to contact those who had failed to
respond. The study was approved by the Medical Ethics
Committee of the Academic Medical Center, University
of Amsterdam (protocol ID MEC10/182).
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cohorts
In the development and external validation cohorts,
baseline measures consisted of participant characteristics,
original ISAR items [23], modified Katz-ADL index score
[26], and other potential predictors of functional decline.
Baseline measures are described in detail elsewhere [27].
A similar set of measures was obtained 6 and 12 months
after baseline assessments.
2.4. Original and modified ISAR
The original ISAR questionnaire consists of six dichoto-
mous self-rated questions on premorbid need of assistance,
increased need of assistance, recent hospitalizations,
impaired memory, visual impairment, and polypharmacy
[23,28]. Range of scores varied from 0 to 6 points [23].
At a cutoff of two points, the overall area under the curve
(AUC) of the ISAR was 0.71 (95% confidence interval
[CI]: 0.68, 0.74), and the sensitivity and specificity were
72% and 58% respectively [23]. A score of 2 indicated
that the patient was at increased risk of functional decline
during the 6 months after the index ED visit. We modified
the ISAR item ‘‘premorbid need of assistance’’ into ‘‘exist-
ing IADL dependence’’ and the item ‘‘increased need of
assistance’’ into ‘‘existing ADL dependence,’’ because we
wanted to specify the questions for a community-dwelling
population and ADL and IADL dependence are known risk
factors for functional decline in a community-dwelling
population [21]. The exact wording of the original ISAR
and modified items were ‘‘Before the illness or injury that
brought you to the emergency, did you need someone to
help you on a regular basis?’’ (ISAR item) into ‘‘Did you
need assistance on a regular basis in the last month (eg, pre-
paring meals, shopping, housekeeping)?’’ (modified ques-
tion) and ‘‘Since the illness or injury that brought you to
the emergency, have you needed more help than usual to
take care of yourself?’’ (ISAR item) into ‘‘Did you need
assistance to take care of yourself in the last 24 hours
(eg, bathing, dressing, toileting)?’’ (modified question).
The ISAR questions were translated based on forward
translation similar to the translation of the ISAR-HP [29].
The translated questions were tested in a pilot study of
two general practitioners, two registered nurses, and 20
participants.
2.5. Potential predictors of functional decline
Other potential predictors of functional decline are age,
sex, ethnicity, level of education, SES, marital status, living
situation, hearing impairment, unintentional weight loss,
depression, falls, multimorbidity, ED visits, limitations in
social activities, and self-rated health [3,24,30e33]. These
predictors were based on the literature and specified by
experienced geriatricians and GPs (see Appendix B for
all screening questions at www.jclinepi.com).2.6. Outcome definition
Functional decline was defined as at least a one-point
decline on the modified Katz-ADL index score at the
12-month follow-up compared with the baseline score
[26]. Death was regarded as the most extreme manifestation
of functional decline. On the basis of previous research [7]
in which the smallest meaningful difference equated to half
a point improvement on a 20-point scale, we determined
the outcome of functional decline on at least one-point
decline on the modified Katz-ADL (15-point scale) index
to ensure that the decline would exceed the smallest mean-
ingful difference.
2.7. Nonrespondent analysis in development cohort
To explore whether nonrespondents were more often
functionally and/or cognitively impaired, a sample of
randomly selected nonrespondents and a sample of
randomly selected participants were invited to participate
in a single home visit conducted by a trained research
nurse. Nonrespondents who participated in this home visit
gave written informed consent before the interview took
place. During the home visit, the same baseline assessments
were performed, along with the Mini-Mental State Exami-
nation (MMSE) [34].
2.8. Statistical analysis
For data analysis, the Statistical Package for Social Sci-
ences (SPSS) version 19.0 and R version 2.13.1 (Hmisc
package) was used.
In both the development and the validation cohorts,
missing data were multiply imputed using participant char-
acteristics, all potential predictors of functional decline, and
the functional outcome [35]. Five imputation data sets were
used. Table 1 lists where missing values occurred before
imputation.
In the development cohort, discrimination of the original
ISAR scale was estimated using the AUC of the receiver
operating characteristics (ROC) curve. Next, we sought to
improve the original ISAR by adding and/or removing vari-
ables associated with functional decline developing a new
model, the ISAR-Primary Care (ISAR-PC). We developed
the new model for the outcome functional decline or death.
Any potential predictor that was univariably associated
with functional decline (P! 0.20) was entered as a candi-
date in a multivariable logistic regression analysis. Nine-
teen predictors met with this criterion. There were
collinearities among the variables ADL dependence, IADL
dependence, and limitations in social activities. As all par-
ticipants with ADL dependence or limitations in social
activities also had IADL dependence, the latter was consid-
ered more comprehensive and was kept in the remaining
list of 18 potential predictors.
Two different selection strategies were used: Model A
comprised the original ISAR items and known clinical
Table 1. Participant characteristics at baseline
Characteristic
Development cohort, n [ 790 Validation cohort, n [ 2,573
Missing values (%) Prevalence (%) Missing values (%) Prevalence (%)
Median age, yr (IQR) 0.0 75.0 (72.0e80.0) 0.0 76.6 (72.9e81.6)
Female sex 0.0 56.7 3.1 53.8
Caucasian 0.1 85.4 0.6 95.7
Level of education 1.0 1.3
Primary school or less 22.4 17.8
Secondary education 61.9 65.7
College or university 14.8 16.5
Socioeconomic status 0.0 0.0
Low (1SD) 32.7 4.5
Intermediate 42.8 83.7
High (1SD) 24.4 11.8
Marital status 0.4 0.3
Married or living together sustainably 51.8 62.8
Divorced or widow or not married 48.2 37.2
Living situation 1.6 0.5
Independent 93.9 94.3
Home for elderly 6.1 5.7
Multimorbidity (2) 0.0 63.5 10.6 59.3
(I)ADL 15 items 3.2 3.6
0 55.9 50.3
1 11.6 20.2
2 32.5 29.5
ADL six items 2.9 3.3
0 75.7 67.3
1 13.3 23.9
2 11.0 8.8
IADL seven items 3.5 4.0
0 61.8 66.1
1 12.3 14.2
2 25.9 19.6
Original ISAR item dependence ADL 2.0 9.0 0.9 6.7
Original ISAR item dependence IADL 1.9 27.9 1.3 21.5
Original ISAR item hospitalizations 1.5 21.0 3.3 19.4
Original ISAR item impaired memory 2.3 16.2 1.5 11.3
Original ISAR item visual impairment 1.4 19.3 9.1 29.6
Original ISAR item polypharmacy (3) 6.2 60.3 1.4 54.6
Hearing impairment 7.0 21.1 8.0 39.9
Unintentional weight loss (6 mo) 2.4 8.3 d d
Depressive symptoms (GDS-2) 5.7 15.6 11.7 5.7
Falls (3 mo) 1.5 13.4 1.4 21.3
Emergency department visit (1 mo) 1.8 6.1 d d
Limitations in social activities 4.6 1.1
Constantly or never 13.8/86.2 8.5/91.5
Self-rated health 1.5 0.9
Bad or good 8.1/91.9 12.5/97.5
Abbreviations: ADL, activities of daily living; IADL, instrumental activities of daily living; ISAR, Identification of Seniors At Risk; GDS, geriatric
depression scale; IQR, interquartile range; SD, standard deviation.
Values are percentages unless stated otherwise.
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unintentional weight loss, falls, and depressive symptoms).
These predictors were all dichotomous and easy to answer
in self-reported questionnaires. Model B comprised all 18
potential predictors, including demographic characteristics.
In both models, we used logistic regression with a manual
stepwise backward elimination (p ! 0.05).
To avoid overfitting, the regression coefficients of the
pooled prediction rule were shrunken using a heuristic
shrinkage factor, based on the degrees of freedom from
the model with all 18 potential predictors [36]. Theheuristic shrinkage factor was estimated for each of the five
imputation sets and averaged.
After recalibrating the intercept, the predictive perfor-
mance of the two new models was first assessed in the
development cohort. In each imputation set, the predicted
probabilities of functional decline were compared with
the observed frequencies to assess the discrimination and
calibration. The discrimination was estimated using the
AUC of the ROC curve. The calibration was assessed using
a calibration plot. The calibration line was described via a
logistic regression model with the observed outcome
Fig. 1. Flowchart of development cohort and validation cohort.
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discrimination, calibration, easy applicability, and parsi-
mony, the final model, ISAR-PC was selected. The ISAR-
PC was then translated into a scorecard using the formula
of Sullivan [40].
The final prediction rule from the development cohort
was applied to the validation cohort. The AUC of the
ROC curve was calculated for each imputation set, and cali-
bration was tested using the calibration plot.
As sensitivity analyses, we repeated all analyses for the
outcome functional decline only excluding deceased patients.
2.8.1. Model based on age only
To benchmark the newly developed ISAR-PC prediction
rule, we compared it with a prediction rule based on age
groups only. In both the development and validation
cohorts, a logistic regression analysis based on age groups
only (cutoff 75.0 years, based on the definition currently
applied by Dutch health care insurance companies) was
performed to identify older persons at increased risk of
functional decline and its discrimination was assessed.3. Results
3.1. Study population
The development cohort comprised 1,113 persons. Fig. 1
shows reasons for exclusion and nonresponse. In total, 790
(76.3%) participants returned the baseline questionnaire
and were included in the study. At baseline, the median
age was 75.0 years, and 44.1% had one or more (I)ADL dis-
abilities (Table 1). Participants who were lost to follow-up at
12 months were more dependent in ADL and IADL and had
more comorbidities and risk factors for functional decline at
baseline (Appendix C at www.jclinepi.com).The validation cohort comprised 4,040 persons. In total,
2,573 (69.1%) participants returned the baseline question-
naire and were included in the study. At baseline, the me-
dian age was 76.6 years, and 49.7% had one or more (I)
ADL disabilities (Table 1).
3.2. Nonrespondents
In the developmental cohort, 7.9% (82 of 1,035) of the
eligible persons were nonrespondents, aged 76.0 years. A
random sample of 32 (39.0%) nonrespondents was willing
to participate in a nonresponse substudy that was initiated in
conjunction with their own GP. Nonrespondents more often
had ADL dependency, cognitive impairment, and lower SES
compared with a random sample of 71 respondents (Table 2).
3.3. Outcomes after 12 months
In the developmental cohort, 31.4% (248 of 790) expe-
rienced functional decline after 12 months and 3.4% died.
Of those who experienced functional decline, 25.7% deteri-
orated in ADL, 51.4% deteriorated in IADL and 22.9%
deteriorated in both. After 12 months, of all (I)ADL inde-
pendent persons at baseline, 85.7% remained in the same
category. In the validation cohort, 31.9% of the participants
experienced functional decline after 12 months.
3.4. Modification of the ISAR
In the development cohort, the AUC of the original
ISAR prediction rule ranged from 0.65 to 0.67 in the five
imputation sets. Model A was selected as the ISAR-PC,
resulting in a three-item prediction model containing age
(odds ratio [OR]: 1.06 per additional year; 95% CI: 1.02,
1.10), dependence in IADL (OR: 2.17; 95% CI: 1.46,
3.22), and self-reported memory problems (OR: 2.22;
Table 2. Baseline characteristics of a random sample of respondents
and nonrespondents who were visited at home by a research nurse
Variable
Respondents
(n [ 71)
Nonrespondents
(n [ 32)a
Median age, yr (IQR) 77.0 (73.0e82.0) 76.0 (72.2e83.0)
Female sex 66.2 50
Caucasian 81.7 75.0
Level of education
Primary or less 29.6 46.9
Socioeconomic status
Low (1SD) 38.6 59.4*
Intermediate 11.4 18.8
High (1SD) 50.9 21.9
ADL six items
0 70.0 43.8**
1 20.0 28.1
2 10.0 28.1
IADL seven items
0 37.1 25.0
1 25.7 28.1
2 37.2 46.9
ISAR-PC positive
(2 points)
55.7 68.8
MMSE Score,
median (IQR)
27.0 (25.0e29.1) 25.0 (19.0e28.2)**
Abbreviations: ADL, activities of daily living; IADL, instrumental
activities of daily living; IQR, interquartile range; MMSE, Mini-
Mental State Examination; SD, standard deviation.
Values are percentages unless stated otherwise.
*P ! 0.05.
**P ! 0.01.
a ManneWhitney U test for continues variables; chi-square test
for dichotomous variables.
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ranged from 0.67 to 0.70 (Table 4) and calibration was
good (Fig. 2A). Including all potential predictors
(Table 3, model B) resulted in similar discriminative prop-
erties but was less feasible because it contained more items,
including the item ethnicity, which is less applicable in a
self-report questionnaire. Excluding deceased participants
gave consistent results (data not shown).
After shrinkage of the regression coefficients by a factor
0.756, the intercept was recalculated, resulting in a predic-
tion model with the following prediction rule for risk of
functional decline:P 5 exp a=ð1þ exp aÞa5 ð  4:533þ 0:584  IADL dependenceþ 0:604
memory problems þ 0:045ageÞThe ISAR-PC comprised two of six original ISAR items
(IADL dependence and impaired memory), and age was
added. In the scorecard, age was turned into three categories
for ease of use: 70e74, 75e84, and 85 (Appendix D at
www.jclinepi.com). The ISAR-PC classified 40.6% of the
population as being at increased risk of functional decline
(Table 4). Within this group, 29.3% of the persons had a pos-
itive ISAR-PC score based on their age alone.3.5. External validation of the ISAR-PC
In the five imputation sets of the validation cohort, the
AUC of the ISAR-PC ranged from 0.63 to 0.64. Calibration
slopes ranged from 0.92 to 0.99 and intercepts from 0.02 to
0.10. In all five sets, the joint hypothesis intercept 5 0 and
slope5 1 could not be rejected (range P-values: 0.09e0.78)
indicating good calibration in all imputations sets (Fig. 2B).
3.6. Selection by age
Selection by persons aged 75 years resulted in an AUC
that ranged from 0.56 to 0.59 in the development cohort
and from 0.56 to 0.57 in the validation cohort. In the devel-
opment cohort, at a cutoff of 75 years, 55.4% of the partic-
ipants were classified as at increased risk of functional
decline (Table 4).4. Discussion
In this prospective cohort study, we modified and vali-
dated the original ISAR screening questionnaire to an in-
strument to identify older persons at increased risk of
functional decline in primary health care. The ISAR-PC
comprises three variables predictive of functional decline:
IADL dependence, self-reported memory complaints, and
age. The ISAR-PC appeared to have moderate discrimina-
tion and was well calibrated. The ISAR-PC is quick and
easy to apply and may serve as an efficient first step in a
two-step approach targeting community-dwelling elderly
at risk of functional decline.
In a population aged!85 years, the ISAR-PC is a more
efficient strategy to identify persons at increased risk of
functional decline than selection based on age alone. The
higher specificity of the ISAR-PC results in less ‘‘false pos-
itives’’; healthy older persons who are falsely identified as
being at increased risk.
Some difference exists between ISAR and ISAR-PC.
The ISAR-PC comprises two of six original ISAR items
(IADL dependence and impaired memory). Age was also
a strong predictor in the original ISAR but was less appli-
cable in the ED setting. ISAR items visual impairment and
polypharmacy were only strong predictors in univariable
analyses developing ISAR-PC. The separate variables asso-
ciated with functional decline in our study also appeared to
be strong predictors of functional decline in several other
studies: age [21,32,41], IADL [21,32,41], and impaired
memory [41]. This also supports the appropriateness of
the individual items included in the ISAR-PC.
The ISAR-PC demonstrated a moderate discrimination
in both the development and the external validation co-
horts. The discriminative ability of several screening in-
struments to identify older persons at increased risk of
functional decline ranges from 0.70 to 0.80 [6,14,21].
Considering the heterogeneous group of community-
dwelling older persons, the relatively long time frame in
Table 3. Univariable and multivariable regression of modified model of functional decline in development cohort
Variable
Univariable Original ISAR Model A ISAR-PC Model B
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Age (yr) 1.09 (1.05, 1.12)*** 1.06 (1.03, 1.09)* 1.07 (1.03, 1.11)*
Female sex a
Non-Caucasian 2.34 (1.52, 3.58)*** 2.28 (1.46, 3.58)*
Level of education a
Primary or less 1.89 (1.14, 3.15)*
Secondary 0.95 (0.58, 1.49)
College (reference) d
Socioeconomic status a
Low 3.03 (1.89, 4.91)***
Middle 1.64 (1.02, 2.63)*
High (reference) d
Not married or widow 1.53 (1.10, 2.12)** a
Living independent 0.32 (0.18, 0.59)*** a
ADL dependence 2.20 (1.65, 4.75)*** a
IADL dependence 2.97 (2.12, 4.17)*** 2.45 (1.74, 3.43)* 2.17 (1.46, 3.22)* 2.04 (1.37, 3.05)*
Hospitalizations (1 yr) 1.16 (0.78, 1.75) a
Impaired memory 2.85 (1.86, 4.37)*** 2.15 (1.35, 3.42)* 2.22 (1.41, 3.51)* 2.03 (1.28, 3.23)*
Visual impairment 1.46 (0.98, 2.17)* a a a
Polypharmacy (O3) 1.43 (0.93, 2.19) a a a
Hearing impairment 1.57 (1.04, 2.35)* a a
Unintentional weight loss (6 mo) 2.08 (1.18, 3.67)** a a
Depressive symptoms (GDS-2) 1.97 (1.29, 3.02)** a a
Falls (3 mo) 2.10 (1.28, 3.44)* a a
Emergency department visit (1 mo) 1.41 (0.71, 2.80) a
Multimorbidity (O2) 2.18 (1.46, 3.26)*** a
Limitations in social activities
(constantly)
2.49 (1.44, 4.32)***
Self-rated health (bad) 2.17 (1.65, 2.86)*** a
Abbreviations: ADL, activities of daily living; GDS, geriatric depression scale; IADL, instrumental activities of daily living; ISAR, Identification of
Seniors At Risk.
Model A (ISAR-PC)5 original ISAR þ predictors related to functional decline that are clinical, dichotomous, and easy to answer in self-reported
questionnaires.
Model B 5 all 18 potential predictors, including demographic characteristics.
*P ! 0.05.
**P ! 0.01.
***P ! 0.001.
a Entered in multivariable model, but eliminated during stepwise backward elimination because of nonsignificance.
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functional decline, it might be difficult to further increase
the AUC. Similar results were described for frailty models
predicting mortality [6,14,42]. However, widely used
prediction models do not always have a high discrim-
inative ability [43]. Their use is weighted against theTable 4. Model performance in development and validation cohort
Variable
Development cohort
Original ISAR ISAR-PC Selection by ag
AUC prediction rulea,b 0.65e0.67 0.67e0.70 0.56e0
Sensitivity (%)b 64.5 62.9 66.7
Specificity (%)b 60.5 69.4 49.7
PPV (%)b 42.7 48.3 37.5
NPV (%)b 79.1 80.5 76.7
Classified as positive (%)b 47.4 40.6 55.4
Abbreviations: AUC, area under the receiver operating characteristics cu
value; PPV, positive predictive value.
a Range in imputation set 1e5.
b Cutoff of two points was used for both original ISAR and ISAR-PC.relevance of outcomes, their face validity, and the available
alternatives. As the differences between prediction models
become smaller, more emphasis may be put on the feasi-
bility of the screening instrument [43].
In terms of feasibility, the ISAR-PC is a simple and short
survey that can be administered as a postal questionnaire inValidation cohort
e (‡75 yr) Original ISAR ISAR-PC Selection by age (‡75 yr)
.59 0.60e0.61 0.63e0.64 0.56e0.57
55.7 47.7 74.6
60.5 72.7 39.5
39.9 45.1 37.0
74.3 74.7 76.5
44.7 33.8 65.0
rve; ISAR, Identification of Seniors At Risk; NPV, negative predictive
Fig. 2. (A) Calibration plot of one of the imputation sets of the development cohort. The predicted probabilities of functional decline are plotted
against the observed (actual) proportions. Error bars represent 95% confidence intervals. The 45 line represents ideal calibration; the nonpara-
metric line represents a spline curve fitted on the realized calibration. A logistic description of the curve gave a calibration slope of 0.86 and inter-
cept of 0.03. The slope and intercept of the calibration line are ideally 1 and 0, respectively (perfect calibration). (B) Calibration plot of one of the
imputation sets of the validation cohort. The predicted probabilities of functional decline are plotted against the observed (actual) proportions.
Error bars represent 95% confidence intervals. The 45 line represents ideal calibration; the nonparametric line represents a spline curve fitted
on the realized calibration. A logistic description of the curve gave a calibration slope of 0.99 and intercept of 0.10.
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does not require any knowledge of medical diagnosis. How-
ever, because it is a prognostic tool that predicts future
functional decline, GPs and registered nurses need training
to comprehend its test characteristics and embed it in their
clinical decision making.
In the coming years, both government and health care
insurance companies will stimulate GPs to deliver system-
atic integrated care for all older people within their practice
population. Therefore, in this study, we chose to invite par-
ticipants to fill out the ISAR-PC on behalf of their GP. In
the development cohort (n 5 1,035), the initial response
on the invitation letter was generally high (n 5 635,
61.4%) and rose even further after one postal reminder
and one telephone call (n 5 790, 76.3%) if they had still
not responded. In regular practice, older persons will be
aware that their GP invites them for a ‘‘checkup’’ to find
out whether they have problems or are in need of additional
care. Therefore, we expect the implementation rate of the
ISAR-PC screening tool to be acceptably high, also outside
the current study setting. Within this setting, extra questions
were asked, because we wanted to develop and validate a
prediction model; but in the implementation phase, only
the ISAR-PC items will remain in the first selection step,
lowering a possible threshold to respond. Nevertheless, ef-
forts to send reminders or call nonrespondents might still be
necessary.
Finally, both in research and in regular care, nonrespon-
dents represent a broad range from very fit to very frail per-
sons. Although the nonresponse substudy did not reveal
large absolute differences, it did show that nonrespondents
have more ADL disabilities and a lower MMSE score at
baseline. Within our data, the main reasons for nonresponse
were no health problems (n 5 208, 18.1%), too ill
(n 5 128, 11.1%), not interested (n 5 174, 15.1%),unknown reason (n 5 206, 17.9%), or no response at all
(n 5 435, 37.8%; Fig. 1). This also illustrates the mixture
of healthy and frail persons in the nonresponse group.
Therefore, nonrespondents should be closely monitored
when starting up a comprehensive intervention strategy to
prevent functional decline.4.1. Limitations
Our study had some limitations. First, 18.5% of the par-
ticipants in the development cohort and 19.0% of the partic-
ipants in the validation cohort had no follow-up at
12 months. This may have biased the results, as loss to
follow-up was associated with increased levels of (I)ADL
dependence at baseline. Selective attrition is a common
problem in studies involving elderly participants [44]. As
we wanted to develop a screening tool for the complete
elderly population, we chose to impute missing data [35].
Second, the original ISAR item ‘‘increased need of
assistance’’ was changed in ‘‘ADL dependence in the last
24 hours.’’ This time frame might have resulted in underre-
porting of ADL dependence. Nevertheless, the conse-
quences of this time frame are probably small because
collinearity existed between ADL and IADL dependence.
Third, the ISAR questions were translated based on for-
ward translation only.
Fourth, we were not able to compare the performance of
ISAR-PC among older persons with and without cognitive
impairment. Prior to the start of the study, patients with a
diagnosis of dementia were excluded by their own GP.
The validity of a dementia diagnosis by a Dutch GP was
shown to be very high, yielding specificity and positive pre-
dictive values of almost 1.0% and 100% [45]. Therefore,
we did not render it necessary to use additional criteria to
further improve the validity of this procedure.
1129J.J. Suijker et al. / Journal of Clinical Epidemiology 67 (2014) 1121e11305. Conclusion
The ISAR-PC is a sensitive, quick, and easy to apply
method to identify persons at increased risk of functional
decline and may serve as an efficient first step in a compre-
hensive diagnosis and intervention strategy. Randomized
clinical studies are needed to assess whether this way of
prioritizing health care efforts is beneficial for patient-
centered outcomes, such as functionality or health-related
quality of life.Acknowledgment
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